HealthEquity (NASDAQ:HQY) Hits New 12-Month High – Should You Buy?

HealthEquity, Inc. (NASDAQ:HQY) reached a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $107.80 and last traded at $107.5850, with a volume of 353,609 shares. The stock had previously closed at $102.03.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HQY. BMO Capital Markets boosted their price target on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a research report on Wednesday, October 21st. Telsey Advisory Group set a $111.00 price objective on HealthEquity in a research report on Friday, August 28th. Weiss Ratings raised HealthEquity from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday. Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a research report on Thursday, September 3rd. Finally, Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $113.53.

HealthEquity Stock Performance

The company’s 50-day moving average is $95.27 and its two-hundred day moving average is $89.22. The company has a market capitalization of $8.92 billion, a P/E ratio of 38.87, a PEG ratio of 1.64 and a beta of 0.22. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The business had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. HealthEquity’s revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 3.94 earnings per share for the current fiscal year.

Insider Buying and Selling at HealthEquity

In other news, Director Adrian Dillon sold 7,632 shares of the firm’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the sale, the director owned 62,395 shares in the company, valued at approximately $6,527,140.95. This trade represents a 10.90% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in HQY. Maridea Wealth Management LLC bought a new stake in HealthEquity during the second quarter worth about $2,753,000. Deutsche Bank AG purchased a new position in shares of HealthEquity in the 2nd quarter worth about $11,986,000. Amundi boosted its holdings in shares of HealthEquity by 33.6% in the 2nd quarter. Amundi now owns 90,327 shares of the company’s stock worth $8,158,000 after purchasing an additional 22,735 shares in the last quarter. Bamco Inc. NY purchased a new position in shares of HealthEquity in the 2nd quarter worth about $67,776,000. Finally, Oppenheimer Asset Management Inc. bought a new position in shares of HealthEquity during the 2nd quarter valued at about $21,079,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.